ENO2 and medulloblastoma: Consistent with these data, we observed a more differentiated phenotype, with significantly reduced malignancy, in tumors from females, as shown by a decreased stem cell population (nestin has been identified as a stem like cell marker for medulloblastoma) [42] and a substantial increase of neuronal (NSE) and glial (GFAP) differentiation markers.